ArticleCureus2026
The Micronizer: A Novel Sharp-Bladed Device for Fat Graft Micronization to Optimize Adipocyte Viability.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reducing fat particle size before injection is anticipated to promote adipocyte survival and facilitate injection through smaller cannulas or needles. We present the Micronizer (Marina Medical, Davie, FL), a Luer-to-Luer connector housing an ultrasharp, double-sided blade that reduces fat particle size through direct sharp dissection rather than mechanical emulsification. Through its dual-configuration design, comprising 2.4- and 1.2-mm apertures, the Micronizer cuts directly along the axis of fat passage, enabling stepwise reduction in particle size. Fat harvested using a 2.5-3.0-mm cannula is processed by repeated passage between syringes through the device. The direct sharp-cutting mechanism is anticipated to reduce fat particle size while limiting compressive forces, with the goal of preserving graft viability. We describe the complete processing protocol. The Micronizer offers a standardized, reproducible method for fat graft micronization that achieves particle sizes anticipated to be optimal for vascularization. Potential applications include revision breast reconstruction, primary breast reconstruction, breast augmentation, and facial rejuvenation. Comparative studies evaluating cell viability and long-term volume retention are warranted to validate the anticipated advantages of direct sharp-blade processing over conventional compressive techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.